Uric acid and cholesterol markers in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at whether certain blood markers (uric acid and cholesterol-related ratios) are linked to diabetes complications. It may help doctors better understand and manage type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You are 18 years or older
- You are either male or female
- You do not have cancer, are not pregnant, and do not have certain kidney, autoimmune, or gout conditions
- You are not taking specific medications like water pills, aspirin, blood pressure drugs (losartan), or cholesterol-lowering drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation relates to complications in people with type 2 diabetes. It is an observational study, meaning you don't receive any treatment — the goal is to understand the connection better.
This study measures how certain blood “fat” markers relate to blood sugar control and inflammation. It may help researchers understand risk factors for heart disease in people with type 1 or type 2 diabetes, pre-diabetes, and people preparing for weight-loss surgery.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks at blood cells and blood type in people with type 2 diabetes to see if they can predict complications. It may help doctors better understand and manage diabetes-related health issues.
This study is looking at whether certain markers of inflammation in the blood can help detect or monitor kidney damage caused by type 2 diabetes. It compares these new markers with a well-known one (MCP-1) to see which might be more helpful for patients.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.